According to a market report by Lucintel, the future of the global panic disorders market looks promising with opportunities in the hospital, mental healthcare centre, and asylum markets. The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.
In this market, tablets
and injections are the major segments of panic disorders market by dosage.
Lucintel forecasts that
tablets will remain the larger segment as it helps in reducing the frequency
and severity of panic attacks.
Within this market,
mental healthcare center will remain the largest segment as it delivers wide
range of services, such as individual and group therapy, medication management,
and crisis intervention.
North America will
remain the largest segment over the forecast period due to rising awareness
towards mental health and presence of highly developed healthcare
infrastructure in the region.
Teva Pharmaceutical
Industries, Sun Pharmaceutical Industries, Mylan, Astrazeneca, Abbott, Baxter,
Bristol-Myers Squibb Company, Eli Lilly And Company, F. Hoffmann-La Roche, and
Glaxosmithkline are the major suppliers in the panic disorders market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Explore Our Latest Publications
Satellite Machine-To-Machine
(M2M) Communication Market
No comments:
Post a Comment